Improving Conversations about Parkinson's Dementia
- PMID: 38696333
- PMCID: PMC11233842
- DOI: 10.1002/mdc3.14054
Improving Conversations about Parkinson's Dementia
Abstract
Background: People with Parkinson's disease (PD) have an increased risk of dementia, yet patients and clinicians frequently avoid talking about it due to associated stigma, and the perception that "nothing can be done about it". However, open conversations about PD dementia may allow people with the condition to access treatment and support, and may increase participation in research aimed at understanding PD dementia.
Objectives: To co-produce information resources for patients and healthcare professionals to improve conversations about PD dementia.
Methods: We worked with people with PD, engagement experts, artists, and a PD charity to open up these conversations. 34 participants (16 PD; 6 PD dementia; 1 Parkinsonism, 11 caregivers) attended creative workshops to examine fears about PD dementia and develop information resources. 25 PD experts contributed to the resources.
Results: While most people with PD (70%) and caregivers (81%) shared worries about cognitive changes prior to the workshops, only 38% and 30%, respectively, had raised these concerns with a healthcare professional. 91% of people with PD and 73% of caregivers agreed that PD clinicians should ask about cognitive changes routinely through direct questions and perform cognitive tests at clinic appointments. We used insights from the creative workshops, and input from a network of PD experts to co-develop two open-access resources: one for people with PD and their families, and one for healthcare professionals.
Conclusion: Using artistic and creative workshops, co-learning and striving for diverse voices, we co-produced relevant resources for a wider audience to improve conversations about PD dementia.
Keywords: Parkinson's; Parkinson's dementia.
© 2024 The Authors. Movement Disorders Clinical Practice published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Figures
References
-
- Williams‐Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW, Barker RA. The CamPaIGN study of Parkinson's disease: 10‐year outlook in an incident population‐based cohort. J Neurol Neurosurg Psychiatry 2013;84(11):1258–1264. - PubMed
-
- Aarsland D, Brønnick K, Larsen JP, Tysnes OB, Alves G. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 2009;72(13):1121–1126. - PubMed
-
- Leroi I, McDonald K, Pantula H, Harbishettar V. Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden. J Geriatr Psychiatry Neurol 2012;25(4):208–214. - PubMed
-
- Dauphinot V, Garnier‐Crussard A, Moutet C, Delphin‐Combe F, Späth HM, Krolak‐Salmon P. Determinants of medical direct costs of care among patients of a memory center. J Prev Alzheimers Dis 2021;8(3):351–361. - PubMed
-
- Carney . “Nobody really knows us” The state of health and social care for Parkinson's‐related dementia; 2021. [cited 2023 22 September]; Available from: https://www.parkinsons.org.uk/sites/default/files/2021-11/PUK0973_Dement....
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical